These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2454179)

  • 1. Keratin immunoreactivity in fine-needle aspiration of the prostate: an aid in the differentiation of benign epithelium from well-differentiated adenocarcinoma.
    Ostrzega N; Cheng L; Layfield LJ
    Diagn Cytopathol; 1988 Mar; 4(1):38-41. PubMed ID: 2454179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
    Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
    Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies.
    Abrahams NA; Ormsby AH; Brainard J
    Histopathology; 2002 Jul; 41(1):35-41. PubMed ID: 12121235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin immunoreactivity in the benign and neoplastic human prostate.
    Brawer MK; Peehl DM; Stamey TA; Bostwick DG
    Cancer Res; 1985 Aug; 45(8):3663-7. PubMed ID: 2410099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.
    Turhan OI; Aydin NE; Sariyüce O; Ozkan S
    Int Urol Nephrol; 1998; 30(6):731-44. PubMed ID: 10195869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates.
    Brawer MK; Nagle RB; Pitts W; Freiha F; Gamble SL
    Cancer; 1989 Feb; 63(3):454-60. PubMed ID: 2463873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy.
    Jiang Z; Wu CL; Woda BA; Dresser K; Xu J; Fanger GR; Yang XJ
    Am J Surg Pathol; 2002 Sep; 26(9):1169-74. PubMed ID: 12218573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV
    Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of the cytoskeleton of human prostatic epithelium. Evidence for disturbed organization in neoplasia.
    Purnell DM; Heatfield BM; Anthony RL; Trump BF
    Am J Pathol; 1987 Feb; 126(2):384-95. PubMed ID: 2435158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of keratin in human prostate.
    Kitajima K; Tökés ZA
    Prostate; 1986; 9(2):183-90. PubMed ID: 2428022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.
    O'Malley FP; Grignon DJ; Shum DT
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(3):191-6. PubMed ID: 1696762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody.
    Oliai BR; Kahane H; Epstein JI
    Am J Surg Pathol; 2002 Sep; 26(9):1151-60. PubMed ID: 12218571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate.
    Shah IA; Schlageter MO; Stinnett P; Lechago J
    Mod Pathol; 1991 Mar; 4(2):220-4. PubMed ID: 1710806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-needle aspiration biopsy in prostate cancer.
    Koizumi JH
    Semin Urol; 1990 Feb; 8(1):19-30. PubMed ID: 1693224
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic mucin in the prostate: can it differentiate adenosis from adenocarcinoma?
    Epstein JI; Fynheer J
    Hum Pathol; 1992 Dec; 23(12):1321-5. PubMed ID: 1281806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
    Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
    Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical detection of the androgen receptor in fine needle aspirates from benign and malignant human prostate.
    Brolin J; Löwhagen T; Skoog L
    Cytopathology; 1992; 3(6):351-7. PubMed ID: 1486178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of restaining prostate needle biopsies with high-molecular weight cytokeratin.
    Dardik M; Epstein JI
    Hum Pathol; 2000 Sep; 31(9):1155-61. PubMed ID: 11014585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of keratin protein in normal prostate and prostatic tumors. An immunohistochemical study.
    Kuwahara T; Nagayama T
    Acta Pathol Jpn; 1987 Feb; 37(2):339-42. PubMed ID: 2440232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.